High-dose melphalan-based chemotherapy and autologous stem-cell transplantation for high-risk osteosarcoma in children: A single-institute experience and review of the literature

MLA

Shinobu Kiyuna, et al. “High-Dose Melphalan-Based Chemotherapy and Autologous Stem-Cell Transplantation for High-Risk Osteosarcoma in Children: A Single-Institute Experience and Review of the Literature.” Pediatric Hematology Oncology Journal, vol. 6, no. 4, Dec. 2021, pp. 171–74. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8c6b9303d7241c3e6b40af7d9702baec&authtype=sso&custid=ns315887.

APA

Shinobu Kiyuna, Jiro Miyamoto, Taichi Uehara, Hideki Sakiyama, Takeshi Higa, Takeshi Yagi, Koichi Nakanishi, Takehiro Matsuda, Tokiko Oshiro, Satoru Hamada, & Nobuyuki Hyakuna. (2021). High-dose melphalan-based chemotherapy and autologous stem-cell transplantation for high-risk osteosarcoma in children: A single-institute experience and review of the literature. Pediatric Hematology Oncology Journal, 6(4), 171–174.

Chicago

Shinobu Kiyuna, Jiro Miyamoto, Taichi Uehara, Hideki Sakiyama, Takeshi Higa, Takeshi Yagi, Koichi Nakanishi, et al. 2021. “High-Dose Melphalan-Based Chemotherapy and Autologous Stem-Cell Transplantation for High-Risk Osteosarcoma in Children: A Single-Institute Experience and Review of the Literature.” Pediatric Hematology Oncology Journal 6 (4): 171–74. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8c6b9303d7241c3e6b40af7d9702baec&authtype=sso&custid=ns315887.